Spread potential and architectural variant of a multiple-drug resistant

Background: Abuse of β-lactam antibiotics and its spread of drug resistance challenged the applicability of antimicrobial agents, enabling polymyxins as a last-line treatment for anti-infections of multi-drug resistant (MDR) pathogen. Polymyxin is applicable to herb breeding/growth prompting and combatting Gram-negative bacteria by combining other antimicrobials by membrane dysfunction, permeability damage, vesicle-vesicle contacts and oxidative stress, with its increasingly ubiquitous resistance. However, the complex mechanisms and high transmission risk of polymyxin resistance pose a severe threat to public health, such as improved colonization advantages and infection risks of Methods: In this study, a polymyxin-resistant Results: Therefore, these candidates were found on one chromosome [an integron-like MDR region not detected in another ST1485 representative strain (O83:H42)] and three plasmids (including Conclusion: Overall, our finding indicates that the co-occurrence of antibiotic resistance factors (such as MDR candidates and LPS architectural variation in this isolate) involves both chromosomal recombination and plasmid dissemination, thereby highlighting important implications for antimicrobial resistance surveillance, molecular epidemiological retrospection, and precision clinical anti-infection.